COMMUNIQUÉS West-GlobeNewswire
-
TOMI Environmental Eyes Massive Expansion Opportunity as Food Industry Seeks Advanced Protection Against Emerging Pathogens
02/06/2026 -
INVO Fertility Announces Fiscal Year 2025 Financial Results
02/06/2026 -
Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission
02/06/2026 -
Inventiva Announces a Comprehensive Capital Structure Optimization including Debt and Equity Financing in Advance of the Anticipated Phase 3 Readout
02/06/2026 -
Inventiva annonce une optimisation globale de sa structure financière, comprenant un financement obligataire et une offre d'American Depositary Shares, en prévision de la publication attendue des résultats de l'essai de phase 3
02/06/2026 -
Hydrafacial Introduces HydraScalp® with Keravive™ as Next Evolution in Scalp Health
02/06/2026 -
Candel Therapeutics Announces Publication in The Lancet Oncology of Pivotal Phase 3 Data Demonstrating Significant Improvement in Disease-Free Survival with Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer
02/06/2026 -
SCIENTURE Receives U.S. Patent Covering REZENOPY™ (Naloxone HCl) Nasal Spray 10 mg, Strengthening Intellectual Property Protection Through 2041
02/06/2026 -
electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub
02/06/2026 -
INmune Bio Reports Statistically Significant Treatment Effect on Advanced White Matter MRI Biomarker in Phase 2 MINDFuL Alzheimer's Trial
02/06/2026 -
Alignment Healthcare Shows How Earlier, Coordinated Care Leads to Better Health and Fewer Emergencies in 2025 Impact Report
02/06/2026 -
ProKidney Appoints Kenneth Locke as Chief Technical Officer
02/06/2026 -
SpyGlass Pharma Appoints Mike Pinder as Vice President, Marketing
02/06/2026 -
Realize Medical Appoints Canadian Technology Leader Andrew Waitman to Board of Directors
02/06/2026 -
UroGen Announces Agreement Resolving Patent Litigation Relating to JELMYTO® (mitomycin) for pyelocalyceal solution
02/06/2026 -
ENLIVEX TO PRESENT QUALITY LONGEVITY MODEL POWERED BY PREDICTION MARKETS TREASURY AT PROOF OF TALK 2026
02/06/2026 -
ORYZON Initiates Patient Enrollment in IDEAL Phase II Trial of Iadademstat in Essential Thrombocythemia
02/06/2026 -
The Ensign Group Acquires Real Estate and Operations in Iowa
02/06/2026 -
The Ensign Group Purchases Memory Care Facility in California
02/06/2026
Pages